The research compound in Xenical^®

Xenical^® is a obesity management medicine from Roche. Its active compound is Orlistat — which is what this catalogue supplies, as a research material.

This is not Xenical^®, and NOVALYTE LABS has no affiliation with Roche. We supply the compound Orlistat for laboratory research only — not for human consumption, diagnostic, therapeutic or veterinary use. Xenical^® is a trademark of Roche, referenced here only to identify the compound.

Xenical is Roche’s brand for orlistat; a lower-dose version is sold over the counter as Alli.

Orlistat is mechanistically unlike everything else in this category: it does not act on appetite signalling at all, but inhibits pancreatic lipase in the gut lumen, reducing dietary fat absorption. Its action is local rather than systemic.

Orlistat is supplied here as a research material, not as the branded medicine.

Orlistat in this catalogue

Other brands using Orlistat

The same compound is marketed under more than one brand, usually because each brand carries a different approved indication.